. 2021 Jun 8;13(6):1091. doi: 10.3390/v13061091

Table 1.

Summary of non-cervical HPV related malignancies.

Malignancy	Prevalence/Incidence	Association with HPV	Prognosis of HPV Positive Disease
Vulvar	3–5% of gynecologic ^†	Direct for some disease, 25–43% ^†	Higher overall survival and disease free survival ^€
Vaginal	1–2% of gynecologic ^‡	Direct for some disease ^‡	Overall survival 35–85% ^ψ
Penile	0.8–4.4/100,000 ^¥	Direct for some disease ^¥, 33–48% ^Φ	Highly variable ^¥,Φ
Anal	27,000/year ^£	>90% ^£	Improved overall survival
Oropharyngeal	12,600 from 2012 to 2016 ^₤	>70% ^₤,§	Improved 3 year survival ^¥,₡

^† [6], ^‡ [7], ^¥ [8], ^£ [9], ^₤ [10], ^§ [11], ^€ [12,13], ^ψ [7,14], ^Φ [15], ^₡ [4,16]. Human Papilloma Virus (HPV).